SILVERARC CAPITAL MANAGEMENT, LLC
•CIK: 1816307•Filing: Q4 2025
**SILVERARC CAPITAL MANAGEMENT, LLC** manages $720M across a diversified portfolio of 68 positions. The fund exhibits significant conviction in select names, with top holdings including ABVX at $56.9M and COGT at $44.2M. Further concentration is evident in BCLYF ($40.7M) and KALV ($39.2M), suggesting a focused, high-conviction investment mandate. This structure indicates active capital deployment into specific market segments.
Total AUM
$691.1M
+ $28.9M in options
QoQ Performance
+0.1%
Positions
64
+ 4 options
Top 10 Concentration
49.7%
Latest Filing
Q4 2025
Top Holdings Allocation
ABVX
COGT
UROG
KALV
CELC
ABVX7.9%
COGT6.1%
UROGEN5.7%
KALV5.4%
CELC5.2%
NUVL4.4%
DNTH4.3%
KOD4.0%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other98.6%
Healthcare1.4%
🚪 Exited Positionssold since Q3 2025
—
UNITED THERAPEUTICS CORP DEL
SOLD
$25.1M
+30 more exited positions
Changes from Q3 2025
NEW21 new positions
↑18 increased
↓27 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023